Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday. Google ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
(Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup ...